114 related articles for article (PubMed ID: 5068262)
21. Hepatic arginase activity in mice bearing Ehrlich ascites carcinoma.
Abreu LA; Abreu RR
Arch Geschwulstforsch; 1968; 31(1):1-4. PubMed ID: 5674790
[No Abstract] [Full Text] [Related]
22. Tumor implants in the mediastinum of mice.
Adlersberg L; Singer JM; Edberg SC
J Reticuloendothel Soc; 1974 May; 15(5):345-60. PubMed ID: 4855274
[No Abstract] [Full Text] [Related]
23. [Effect of L-asparaginase on phagocytosis in the reticulo-endothelial system of the mouse].
Nothdurft W
Arzneimittelforschung; 1972 Jun; 22(6):989-91. PubMed ID: 4559160
[No Abstract] [Full Text] [Related]
24. Hyaluronidase activity in murine leukaemia & lymphoma.
Chakraborti AS; Basu A; Mitra S
Indian J Exp Biol; 1982 May; 20(5):423-4. PubMed ID: 6957398
[No Abstract] [Full Text] [Related]
25. Intraperitoneal administration of carrier erythrocytes in dogs: an improved method for delivery of L-asparaginase.
DeLoach JR; Andrews K; Satterfield W; Keeling M
Biotechnol Appl Biochem; 1990 Jun; 12(3):331-5. PubMed ID: 2360993
[TBL] [Abstract][Full Text] [Related]
26. Asparaginase clearance: influence of the LDH-elevating virus.
Riley V; Campbell HA; Stock CC
Proc Soc Exp Biol Med; 1970 Jan; 133(1):38-42. PubMed ID: 5412359
[No Abstract] [Full Text] [Related]
27. The induction of rhodanese and cystathionase activities in regular and neoplastic tissues.
Wlodek L; Szczepkowski T; Buczulska L
Folia Biol (Krakow); 1971; 19(4):449-55. PubMed ID: 5149428
[No Abstract] [Full Text] [Related]
28. Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
Mordarski M; Chylińska B; Urbański T
Arch Immunol Ther Exp (Warsz); 1970; 18(6):679-99. PubMed ID: 5493086
[No Abstract] [Full Text] [Related]
29. Prediction of response to L-asparaginase therapy.
Prager MD
Natl Cancer Inst Monogr; 1971 Dec; 34():257-62. PubMed ID: 5140872
[No Abstract] [Full Text] [Related]
30. The effect of endo- and exogenous melanin on Zn2+ and Co2+ elimination and distribution in mice.
Nogaj P; Buszman E; Swiatkowska L; Wilczok T
Acta Biochim Pol; 1995; 42(1):83-8. PubMed ID: 7653166
[TBL] [Abstract][Full Text] [Related]
31. Regeneration, tumor, dietary, and L-asparaginase effects on asparagine biosynthesis in rat liver.
Patterson MK; Orr GR
Cancer Res; 1969 Jun; 29(6):1179-83. PubMed ID: 4894450
[No Abstract] [Full Text] [Related]
32. The effect of 1, 3-bis(2-chloroethyl)-nitrosourea on nicotinamide adenine dinucleotide glycohydrolase of mouse and rat neoplastic and normal tissues.
Green S
Cancer Res; 1966 Dec; 26(12):2481-4. PubMed ID: 5955599
[No Abstract] [Full Text] [Related]
33. [Ascitic tumor produced by BHK-21 cells (clone 13) in hamsters exposed to whole body roentgen irradiation].
Mayo J; Moreira JL; Lombardo JH; Conti CJ; Rivenson S
Arch Exp Veterinarmed; 1971; 25(5):853-62. PubMed ID: 4335401
[No Abstract] [Full Text] [Related]
34. [The cystathionase-rodanase system].
Szczepkowski T; Partyka-Wlodek L
Folia Med Cracov; 1974; 16(1):133. PubMed ID: 4838559
[No Abstract] [Full Text] [Related]
35. Clinical evaluation of L-asparaginase. Introduction.
Burchenal JH; Karnofsky DA
Cancer; 1970 Feb; 25(2):241-3. PubMed ID: 4905151
[No Abstract] [Full Text] [Related]
36. [Asparaginase in experimental allergic encephalomyelitis. IV. The relation of asparaginase of lymph nodes to asparaginase of the central nervous system in the process of development of experimental allergic encephalomyelitis in guinea pigs. The relationship between the histologic finding, the clinical picture and the asparaginase in the central nervous system].
Valovicová E; Rajcáni J; Turský T; Brozman M
Z Gesamte Exp Med Einschl Exp Chir; 1966; 140(3):256-67. PubMed ID: 5992172
[No Abstract] [Full Text] [Related]
37. In vivo and in vitro effects of the L-asparaginase fraction of guinea pig serum on the 6C3HED ascites lymphosarcoma.
Borella L; Journey LJ; Hiramoto R
Cancer Res; 1966 Dec; 26(12):2451-60. PubMed ID: 6012605
[No Abstract] [Full Text] [Related]
38. Enhancement of metastases by L-asparaginase in a mouse tumor system.
Deodhar SD
J Reticuloendothel Soc; 1971 Aug; 10(2):212-22. PubMed ID: 5120416
[No Abstract] [Full Text] [Related]
39. [Parameters for the clinical use of L-asparaginase].
Mistretta AP; Astaldi G; Tassi GC; DeBarbieri A
Ann Ist Super Sanita; 1971; 7(2):405-7. PubMed ID: 5154664
[No Abstract] [Full Text] [Related]
40. [Blood level course in humans following administration of 2 various kinds of L-asparaginase].
Pütter J; Gehrmann G
Klin Wochenschr; 1969 Dec; 47(24):1324-6. PubMed ID: 5382022
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
